av/glaxosmithkline--big.svg

NSE:GLAXO

GlaxoSmithKline Pharmaceuticals Limited

  • Stock

INR

Last Close

2,964.60

02/05 08:51

Market Cap

431.92B

Beta: 0.09

Volume Today

152.98K

Avg: 51.02K

PE Ratio

64.03

PFCF: 16,370.88

Dividend Yield

1.31%

Payout:0%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '24
Mar '25
revenue
27.64B
-
29.08B
5.25%
28.71B
1.27%
31.28B
8.94%
32.24B
3.08%
31.99B
0.79%
32.78B
2.47%
32.52B
0.80%
34.53B
6.20%
34.42B
0.33%
37.49B
8.93%
cost of revenue
13.33B
-
14.82B
11.12%
13.28B
10.39%
14.45B
8.79%
13.98B
3.25%
13.95B
0.21%
14.50B
3.94%
12.85B
11.37%
21.72B
69.02%
14.20B
34.62%
13.91B
2.04%
gross profit
14.30B
-
14.27B
0.23%
15.44B
8.19%
16.84B
9.07%
18.27B
8.51%
18.04B
1.24%
18.28B
1.34%
19.67B
7.57%
12.81B
34.85%
20.22B
57.78%
23.58B
16.64%
selling and marketing expenses
1.92B
-
1.84B
4.19%
1.54B
15.98%
2.06B
33.34%
2.01B
2.16%
1.72B
14.60%
1.84B
6.86%
1.66B
9.52%
1.80B
8.13%
1.80B
0%
general and administrative expenses
65.70M
-
55.75M
15.13%
368.75M
561.38%
277.32M
24.79%
170.48M
38.53%
184.70M
8.34%
425.92M
130.60%
291.87M
31.47%
486.29M
66.61%
486.29M
0%
selling general and administrative expenses
1.98B
-
1.89B
4.55%
1.91B
1.03%
2.34B
22.13%
2.18B
6.48%
1.90B
12.81%
2.26B
18.87%
1.95B
13.65%
3.85B
96.89%
7.36B
91.20%
5.80B
21.21%
research and development expenses
23.27M
-
21.80M
6.29%
18.07M
17.11%
25.44M
-
25.44M
0%
other expenses
7.16M
-
7.20M
0.57%
8.76B
121,553.79%
8.93B
2.01%
11.29B
26.37%
9.63B
14.72%
9.03B
6.20%
10.33B
14.36%
-483.84M
104.68%
-483.84M
0%
cost and expenses
22.99B
-
25.16B
9.41%
23.95B
4.80%
25.72B
7.37%
27.45B
6.75%
25.48B
7.18%
25.79B
1.23%
25.13B
2.56%
26.07B
3.75%
20.94B
19.71%
19.71B
5.87%
operating expenses
9.66B
-
10.34B
7.05%
10.67B
3.19%
11.27B
5.61%
13.48B
19.57%
11.53B
14.41%
11.30B
2.06%
12.28B
8.75%
4.36B
64.53%
7.38B
69.44%
5.80B
21.48%
interest expense
4.21M
-
2.50M
40.66%
1.89M
24.36%
5.54M
193.13%
63.35M
1,042.97%
35.31M
44.26%
19.96M
43.48%
18.10M
9.32%
17.99M
0.62%
17.99M
0%
13.10M
27.17%
ebitda
6.02B
-
4.92B
18.27%
5.63B
14.43%
7.02B
24.69%
6.26B
10.81%
8.41B
34.34%
8.37B
0.41%
9.05B
8.08%
9.15B
1.14%
8.87B
3.06%
11.77B
32.69%
operating income
4.64B
-
3.93B
15.39%
5.25B
33.66%
6.53B
24.45%
5.43B
16.83%
7.61B
40.20%
7.69B
1.01%
8.39B
9.11%
8.46B
0.78%
13.60B
60.83%
17.79B
30.76%
depreciation and amortization
247.76M
-
263.47M
6.34%
379.86M
44.18%
485.91M
27.92%
826.78M
70.15%
792.84M
4.11%
681.86M
14.00%
657.70M
3.54%
167.90K
99.97%
695.36M
414,062.42%
667.90M
3.95%
total other income expenses net
1.15B
-
1.19B
2.73%
151.84M
87.19%
295.59M
94.66%
-2.37B
903.17%
-2.11B
11.13%
99.04M
104.69%
-27.80M
128.07%
-295.62M
963.38%
-5.44B
1,740.24%
-5.19B
4.64%
income before tax
5.79B
-
5.11B
11.78%
5.40B
5.63%
6.83B
26.43%
3.06B
55.21%
5.50B
80.05%
7.79B
41.52%
8.36B
7.36%
8.16B
2.42%
8.16B
0%
12.60B
54.36%
income tax expense
2.03B
-
1.74B
13.95%
1.89B
8.53%
2.37B
25.38%
2.13B
10.42%
1.92B
9.50%
3.98B
107.06%
2.29B
42.56%
2.26B
1.11%
2.26B
0%
3.32B
46.89%
net income
3.77B
-
3.37B
10.62%
3.51B
4.13%
4.45B
26.99%
932.05M
79.07%
3.58B
284.26%
3.81B
6.32%
6.11B
60.38%
5.90B
3.39%
5.90B
0%
9.28B
57.23%
weighted average shs out
84.70M
-
169.41M
100%
169.41M
0%
169.41M
0%
169.41M
0%
169.41M
0%
169.41M
0%
169.41M
0%
169.40M
0.00%
169.41M
0.00%
169.41M
0%
169.39M
0.01%
weighted average shs out dil
84.70M
-
169.41M
100%
169.41M
0%
169.41M
0%
169.41M
0%
169.41M
0%
169.41M
0%
169.41M
0%
169.40M
0.00%
169.41M
0.00%
169.41M
0%
169.39M
0.01%
eps
0
-
22.21
Infinity%
19.88
10.49%
20.70
4.12%
26.29
27.00%
5.50
79.08%
21.14
284.36%
22.48
6.34%
36.05
60.36%
34.83
3.38%
34.83
0%
54.76
57.22%
epsdiluted
0
-
22.21
Infinity%
19.88
10.49%
20.70
4.12%
26.29
27.00%
5.50
79.08%
21.14
284.36%
22.48
6.34%
36.05
60.36%
34.83
3.38%
34.83
0%
54.76
57.22%

All numbers in INR (except ratios and percentages)